Cargando…
Medication-Wide Association Study Plus (MWAS+): A Proof of Concept Study on Drug Repurposing
The high cost and time for developing a new drug or repositioning a partially-developed drug has fueled interest in “repurposing” drugs. Drug repurposing is particularly of interest for Alzheimer’s disease (AD) or AD-related dementias (ADRD) because there are no unrestricted disease-modifying treatm...
Autores principales: | Cheng, Yan, Zamrini, Edward, Ahmed, Ali, Wu, Wen-Chih, Shao, Yijun, Zeng-Treitler, Qing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9503040/ https://www.ncbi.nlm.nih.gov/pubmed/36135833 http://dx.doi.org/10.3390/medsci10030048 |
Ejemplares similares
-
A medication-wide association study (MWAS) on repurposed drugs for COVID-19 with Pre-pandemic prescription medication exposure and pregnancy outcomes
por: Davidson, Lena, et al.
Publicado: (2022) -
Enhancing Clinical Data Analysis by Explaining Interaction Effects between Covariates in Deep Neural Network Models
por: Shao, Yijun, et al.
Publicado: (2023) -
Hybrid Value-Aware Transformer Architecture for Joint Learning from Longitudinal and Non-Longitudinal Clinical Data
por: Shao, Yijun, et al.
Publicado: (2023) -
Hybrid Value-Aware Transformer Architecture for Joint Learning from Longitudinal and Non-Longitudinal Clinical Data
por: Shao, Yijun, et al.
Publicado: (2023) -
Alzheimer’s Disease and Alzheimer’s Disease-Related Dementias in Older African American and White Veterans
por: Cheng, Yan, et al.
Publicado: (2020)